Page 485 - fbkCardioDiabetes_2017
P. 485

Cardio Diabetes Medicine 2017                                    461






































































                 risk of hypotension and renal insufficiency and may   symptomatic patients with HFrEF, despite treatment
                 lead  to angioedema, as  well.   Ivabradine can  be   with an ACEI and, in most cases, a diuretic, but have
                 beneficial to reduce HF  hospitalization  for  patients   not  been tested in congested or decompensated
                 with symptomatic (NYHA  class  II-III)  stable chronic   patients. There is consensus
                 HFrEF (LVEF ≤35%) who are receiving GDEM, including   that  beta-blockers  and ACEIs  are  complementary,
                 a beta blocker at maximum tolerated dose, and who   and can be started together as soon as the diagnosis
                 are  in sinus rhythm with a heart rate  of  70 bpm  or   of HFrEF  is  made. There  is no evidence favouring
                 greater at rest.( ACC/AHA class IIa).
                                                                    the initiation of treatment with a beta-blocker before
                                                                    an ACEI has been started. Betablockers  should be
                 Beta-blockers                                      initiated in clinically stable patients at a low dose and
                 Beta-blockers  reduce mortality and  morbidity in
                                                    Cardio Diabetes Medicine
   480   481   482   483   484   485   486   487   488   489   490